# Pharmcore Inc. dba Hallandale Pharmacy – FDA Inspection, Jul 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/pharmcore-inc-dba-hallandale-pharmacy/560ac632-c02a-4d54-9bc3-7077c0fb3817
Source feed: FDA_Inspections

> FDA inspection 1058812 of Pharmcore Inc. dba Hallandale Pharmacy, July 13, 2018. Classification: Official Action Indicated (OAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058812
- Company Name: Pharmcore Inc. dba Hallandale Pharmacy
- Inspection Date: 2018-07-13
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1272730 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/pharmcore-inc-dba-hallandale-pharmacy/303070fe-5fcd-409f-8d0d-fe1eed5bd3b9)
- FDA Inspection 1152593 - 2021-09-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)
- [FDA Associated Person](https://www.keypedia.com/people/melinda-lee/fcf10f91-4939-48c7-b987-722b7ad55097)

Company: https://www.keypedia.com/companies/pharmcore-inc-dba-hallandale-pharmacy/3cfc388f-8861-4cad-9bff-dc101ad7d028

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c